ADENTRA (TSE:ADEN – Free Report) had its price objective increased by Desjardins from C$41.00 to C$47.00 in a report issued on Monday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
Several other equities research analysts also recently issued reports on the company. Scotiabank set a C$31.00 price objective on ADENTRA and gave the company a “sector perform” rating in a report on Thursday, June 19th. National Bankshares boosted their target price on ADENTRA from C$41.00 to C$42.50 and gave the stock an “outperform” rating in a research note on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, ADENTRA currently has a consensus rating of “Buy”.
ADENTRA Price Performance
ADENTRA Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 31st will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Monday, October 20th. ADENTRA’s dividend payout ratio is currently 23.50%.
ADENTRA Company Profile
Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.
Read More
- Five stocks we like better than ADENTRA
- What is the NASDAQ Stock Exchange?
- Datavault AI: The New AI Contender Backed by Big Funding
- 5 discounted opportunities for dividend growth investors
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.